Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Prasugrel in Healthy Male Subjects
NCT02075268Phase 1Unknown
- Sponsor
- Asan Medical Center
- Start
- Jan 2014
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of prasugrel in acute coronary syndrome (ACS) (2 arms), sponsored by Asan Medical Center. Primary endpoints: Plasma R-138727 concentration at 24 hours and Plasma R-95913 concentration at 24 hours. Status: unknown.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02075268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075268.